China boosts export controls on dual use items, state media says
Gunmen kill two Mozambique opposition figures ahead of election protests
India ex-official charged in US murder plot had been arrested in Delhi attempted murder case
With brain injuries a growing problem, the US military tests how to protect troops from blasts
Israeli strikes kill 32 in Gaza, siege around hospitals tightens, health officials say
October is Cybersecurity Awareness Month. Here's how to stay safe from scams
Italian coastguard vessel picks up migrants from Albania to transfer them to Italy
No. 13 BYU outlasts Oklahoma State to remain undefeated, winning 38-35 on TD with 10 seconds left
Belgrade's landmark Hotel Yugoslavia faces likely demolition, with many opposed
Cleveland closer Clase stumbles again as Yankees score 2 runs in ninth off All-Star in 8-6 ALCS win
(Reuters) - U.S. industrial conglomerate 3M said on Thursday its independent healthcare business would be called Solventum following its spinoff.
3M disclosed plans to spin off its healthcare business into a listed company last year, in which the U.S. industrial giant would retain a 19.9% stake.
The plan came amid litigations from military members who used the industrial giant's allegedly defective earplugs.
The healthcare unit, which focuses on wound care, oral care and healthcare technology, reported about $8.4 billion in sales in 2022.
3M had said in August that Bryan Hanson would be the chief executive officer of the healthcare company.
The company said the name Solventum originates from two words "solving" and "momentum", symbolizing breakthrough solutions and swifter innovation.
The spinoff is expected to be completed in the first half of 2024.
(Reporting by Christy Santhosh; Editing by Shilpi Majumdar)
